| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 38,120 | 45,331 | 59,664 | 41,599 | | Cost of Revenue | 29,736 | 34,219 | 47,949 | 32,678 | | | Gross Profit | 8,384 | 11,112 | 11,715 | 8,921 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,970 | 5,838 | 7,854 | 7,024 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,414 | 5,274 | 3,861 | 1,897 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 415 | (175) | 437 | (134) | | Earnings Before Interest And Taxes | 1,829 | 5,099 | 4,298 | 1,763 | | Interest Expense | 281 | 273 | 266 | 259 | | Income Before Tax | 1,548 | 4,826 | 4,032 | 1,504 | | Income Tax Expense | 1,010 | 1,573 | 614 | 658 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 538 | 3,253 | 3,418 | 846 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 538 | 3,253 | 3,418 | 846 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $538 | $3,253 | $3,418 | $846 |
|
0.07% Nasdaq 
Income Statement
